Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Conditions:   Stage I Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma Interventions:   Drug: Bicalutamide;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Drug: Raloxifene Hydrochloride Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials